PATENT CLAIM ANALYSIS

Application Number: 15908013
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["424", "452000"]

Abstract:
Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.

Claim (Index 19):
The tablet according to  claim 1 , wherein the API is esketamine, the first gelling polymer is HPMC, and the second gelling polymer is a carbomer.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 88.0
- Lexical Diversity: 1.54286
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14539231', '14527215', '15423388', '15210760', '14132500']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8888611032453991
- 35 USC 102 Novelty (BERT): 0.6753893033477093
- Combined Prediction Score: 0.8675139232556301
- Mean Citation Score: 708.105824
- Max Citation Score: 816.5063
- Similarity Product: 626.6512459688843

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test